THE Therapeutic Goods Administration (TGA) has posted a reminder to sponsors of biological medicines that they must have in place a "robust biovigilance system" including reporting and recording standards around any public threats or adverse events.
See details at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Dec 17
